NCT07127965 Exercise Adherence and Cognitive Decline: Phase 2
| NCT ID | NCT07127965 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Boulder |
| Condition | Cognitive Decline |
| Study Type | INTERVENTIONAL |
| Enrollment | 226 participants |
| Start Date | 2025-11-05 |
| Primary Completion | 2028-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 226 participants in total. It began in 2025-11-05 with a primary completion date of 2028-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to conduct a test of a goals-based program to help people exercise more. This program was designed for individuals aged 45-65 from the Black community. Low levels of physical activity are related to health problems such as heart disease, diabetes, and cognitive decline. People of color are more negatively impacted by these conditions and have also historically been underrepresented by research seeking to increase physical activity. The investigators have developed this goals-based exercise promotion program with the help of a Black-led community-based organization (The Gyedi Project) and a Community Advisory Board made up of stakeholders in the Black community.
Eligibility Criteria
Inclusion Criteria: * \<3 incorrect responses on the Pfeiffer Mental Status Questionnaire * Ages 45 to 65 * Consent to be randomized to conditions * Planning to remain in the Denver metro area for the next 14 months * Identify as Black or African American Exclusion Criteria: * Currently physically active (i.e., \>90 min/week of moderate PA or \>40 min/week of vigorous PA consistently for the past 6 months) * On antipsychotic medications or currently under treatment for any serious psychiatric disorder including Alzheimer's or dementia * Inability to walk 3 blocks without chest pain, shortness of breath, or lightheadedness * Inability to climb 2 flights of stairs without chest pain, shortness of breath, or lightheadedness PCP Exclusion Criteria: * Answers "yes" to 1 or more of the 7 general questions of the PAR-Q+ and answers yes to any of the follow up questions. * Blood pressure at baseline is greater than 160/100 * Blood pressure at baseline is between 140/90 - 160/100 and the participant is currently taking blood pressure medication * Blood pressure \> 210/90 mmHg (for men) or \> 190/90 mmHg (for women) immediately after exercise
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07127965 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 65 Years, studying Cognitive Decline. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07127965 currently recruiting?
Yes, NCT07127965 is actively recruiting participants. Contact the research team at themovestudy@gmail.com for enrollment information.
Where is the NCT07127965 trial being conducted?
This trial is being conducted at Aurora, United States, Boulder, United States.
Who is sponsoring the NCT07127965 clinical trial?
NCT07127965 is sponsored by University of Colorado, Boulder. The trial plans to enroll 226 participants.